MedPath

Evaluating the Effects of 6-weeks Interval Aerobic Exercise and Respiratory Muscle Training on some of Cardiopulmonary and Muscular Indicators of Chronic Obstructive Pulmonary Disease Patients

Not Applicable
Conditions
Chronic Obstructive Pulmonary Disease.
Chronic obstructive pulmonary disease, unspecified
J44.9
Registration Number
IRCT20190702044075N1
Lead Sponsor
Shiraz University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Chronic Obstructive Pulmonary Disease Stage 3 and 4

Exclusion Criteria

Uncontrolled cardiovascular disease ( decompensated CHF, uncontrolled arrhythmia, myocardial infarction or unstable angina during recent 6 weeks)
uncontrolled hypertension (systolic blood pressure more than 180 mm-Hg / diastolic blood pressure more than 110 mm Hg)
any musculo-skeletal disease and Motor restriction which preclude exercise program
moderate to severe COPD exacerbation leading to hospital admission during recent 6 weeks
performing regular exercise or participation in cardiac or pulmonary rehabilitation during recent 6 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FEV1 (Forced Expiratory Volume in the first Second): is the volume of air that can forcibly be blown out in the first second, after full inspiration. In another words, this indicator shows the volume of expiratory air in the first second of vital capacity. (Vital Capacity; The maximum volume of air that can be blown out after a very deep inspiration). Timepoint: Before and after the 6th and final week of the intervention, as a Pulmonary Function Test (PFT). Method of measurement: Using spirometry, measured in Liters.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath